
 
 
 
 
 
 
 
 
 What is claimed is:  
   
 1. Monoclonal antibodies produced by one of the cell lines MAK<PSA-ACT>M 4.6.374, MAK<PSA-ACT>M 4.3.2 or MAK<PSA-ACT>M 6.13.64 with the depository numbers DSM ACC 2281, DSM ACC 2283 and DSM ACC 2282, respectively. 
 
   
 
 
 
 
 
 
 
 
